48,830
edits
Difference between revisions of "Invasive breast cancer"
Jump to navigation
Jump to search
Invasive breast cancer (view source)
Revision as of 19:53, 27 November 2011
, 19:53, 27 November 2011→HER2 scoring
| Line 115: | Line 115: | ||
*Evaluated on the invasive component. | *Evaluated on the invasive component. | ||
===HER2 scoring=== | ===HER2 scoring=== | ||
Immunohistochemical based testing:<ref name=Ref_Lester241-2>{{Ref Lester|241-2}}</ref><ref name=Lester3_87>{{Ref Lester3|87}}</ref> | Immunohistochemical based testing:<ref name=Ref_Lester241-2>{{Ref Lester|241-2}}</ref><ref name=Lester3_87>{{Ref Lester3|87}}</ref><ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2009/InvasiveBreast_09protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2009/InvasiveBreast_09protocol.pdf]. Accessed on: 27 November 2011.</ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
| '''Score''' | | '''Score''' | ||
| Line 146: | Line 146: | ||
|- | |- | ||
| '''3+''' | | '''3+''' | ||
| strong | | uniform staining (used to be ''strong'') | ||
| >10% | | >30% (used to ''>10%'') | ||
| complete | | complete | ||
| HER2 blocker | | HER2 blocker | ||